Home/Filings/4/0001209191-22-002214
4//SEC Filing

Lindmark Bertil 4

Accession 0001209191-22-002214

CIK 0001800315other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:00 PM ET

Size

5.6 KB

Accession

0001209191-22-002214

Insider Transaction Report

Form 4
Period: 2022-01-04
Lindmark Bertil
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-04+118,750118,750 total
    Exercise: $3.24Exp: 2032-01-03Common Stock (118,750 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to such option vested and became exercisable on January 4, 2023 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Issuer

Galecto, Inc.

CIK 0001800315

Entity typeother

Related Parties

1
  • filerCIK 0001825778

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:00 PM ET
Size
5.6 KB